Table 1.
EVs type | Component | Parts of EXOs/EVs | Study model | DOX administration | Distribution | Ref |
---|---|---|---|---|---|---|
EXOs | circ-SKA3 | circRNA | Human cardiomyocyte-like AC16 cells | 5 μM for 24 h | — | [110] |
EVs | PYGB | Protein | Male C57BL/6J mice | 20 mg/kg, IP; a single dose | Serum | [107] |
EXOs | miR-502 | miRNA | Dogs diagnosed with sarcoma | 30 mg/m2 for dogs > 15 kg and 1 mg/kg for dogs < 15 kg, IV; 2 to 3 weeks for 5 injections | Serum | [109] |
EXOs: exosomes; EVs: extracellular vesicles; PYGB: brain/heart glycogen phosphorylase; IP: intraperitoneal injection; IV: intravenous injection.